Publication strengthens NetraMark's case for biomarker-guided enrichment, individualized response modeling, and explainable AI for trial design in psychedelic clinical development.

Neuroscientist Dr. Kelly Tremblay Explains Why Protecting Hearing is Key to Brain Health in the New Brain Bytes Episode - ...

"This will evolve pretty rapidly," said the company's CEO, who has ties to UC Berkeley.

A UC Davis researcher conducts laboratory work. The university was recently awarded a $15.8 million grant to fund a study of ...

Gary Woodland says he has "no idea" when he may suffer a PTSD episode but knowing security is close at hand at the Masters ...

Does this sound like you? Women over 50 spend billions of dollars on skin care each year, hoping for the best. Unfortunately, ...

Scottie Barnes had 25 points, eight rebounds and five assists as Toronto earned a critical 121-95 win over the Miami Heat on ...

Major champion Gary Woodland says he is "battling every day" with post-traumatic stress disorder, following an operation to ...

Adults are finding creative, intentional ways to see people face to face. It just looks a bit different than we’re used to ...

For Southampton footballer Issy Watts, growing up provided obstacles and unanswered questions before learning of her autism ...

Denali plans to continue clinical development of DNL593, which is designed to deliver progranulin to the brain using TransportVehicle™ technologyResults from ongoing Phase 1/2 study in patients with F ...

Experts who work on conversion therapy talked to LGBTQ Nation about just how conversion therapy harms its victims.